<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03685487</url>
  </required_header>
  <id_info>
    <org_study_id>18CH049</org_study_id>
    <secondary_id>2018-001505-90</secondary_id>
    <nct_id>NCT03685487</nct_id>
  </id_info>
  <brief_title>Decolonization of Patients Carrying S. Aureus Before Cardiac Surgery: Study of the Risk Factors Associated With Failure</brief_title>
  <acronym>STAdécol</acronym>
  <official_title>Decolonization of Patients Carrying S. Aureus Before Cardiac Surgery: Study of the Risk Factors Associated With Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Staphylococcus aureus nasal carriage is a well-known risk factor for S. aureus surgical site
      infections (SSI). According to a recent study demonstrating 60% reduction risk of SSI due
      this bacterium after patients' screening and decolonization, recent French and WHO guidelines
      recommend in cardiac surgery the decolonization of nasal S. aureus carriers before surgery.
      In practice the decolonization procedures are not well-defined according notably to the
      duration and time of delivery before surgery and doses of topical antimicrobial drugs. The
      aim of the proposed study is to investigate the factors associated with failures of S. aureus
      decolonization: carriage state, compliance with treatment, S. aureus capacity of
      internalization in nasal epithelial cells, resistance to antimicrobial drugs used. This study
      will allow (i) to measure the frequency of patients with residual S. aureus carriage just
      before surgery, whatever they have been decolonized or not, (ii) to characterize the S.
      aureus nasal carriage state of patients before surgery, and (iii) to investigate the adding
      value of mupirocin dosage in the nose and urines of decolonized patients as a marker of
      compliance and efficacy of the decolonization process.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 12, 2019</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of participants with failure of decolonization of nasal carriers of S. aureus</measure>
    <time_frame>just before surgery</time_frame>
    <description>These patients were screened positive for S. aureus in nasal swab culture collected during the preoperative consultation of cardiac surgery, who received a decolonization prescription and who are again detected positive in culture for S. aureus on the nasal collection performed on admission to the surgery department (just before surgery).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of nasal carriage of S. aureus just prior to cardiac surgery in all patients</measure>
    <time_frame>before surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of nasal carriage of S. aureus 3 months after cardiac surgery in all patients</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between nasal dosing of mupirocin and compliance</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between mupirocin urine metabolite assay associated with mupirocin nasal dosing and decolonization efficacy (failure or not).</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Staphylococcus Aureus</condition>
  <arm_group>
    <arm_group_label>patients with failures of decolonization S. aureus</arm_group_label>
    <description>patients with failures of decolonization S. aureus in their nose</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>decolonization</intervention_name>
    <description>current practice : V1 : consultation to the service : nasal sample for all 5 days before surgery : order sent with decolonization procedure : nasal mupirocin, shower and mouthwash V2 : admission to the service : nasal sample for all and urine sample for decolonized patients V3 : nasal sample for all</description>
    <arm_group_label>patients with failures of decolonization S. aureus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>compliance questionnaire</intervention_name>
    <description>We asked if the patient has done the whole decolonization procedure</description>
    <arm_group_label>patients with failures of decolonization S. aureus</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study will be offered to all major patient who needs cardiac surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient to benefit from cardiac surgery scheduled at Saint-Etienne University Hospital

          -  Surgery of first intention (no resumption)

          -  Patient affiliated or entitled to a social security scheme

          -  Patient agreeing to participate in the study and having signed the informed consent

        Exclusion Criteria:

          -  Surgery in a context of infection

          -  Surgery in an emergency and semi-emergency context

          -  Protected major patient

          -  Pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florence GRATTARD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florence GRATTARD, MD</last_name>
    <phone>0477828105</phone>
    <phone_ext>+33</phone_ext>
    <email>florence.grattard@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie PEURIERE</last_name>
    <phone>0477829272</phone>
    <phone_ext>+33</phone_ext>
    <email>marie.peuriere@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu Saint-Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence GRATTARD, MD</last_name>
      <email>florence.grattard@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Florence GRATTARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe BERTHELOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisabeth BOTELHO NEVERS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Pierre FAVRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul VERHOEVEN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie GAGNAIRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Salvatore CAMPISI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jonathan BENTZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne CARRICAJO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frédéric LUCHT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruno POZZETTO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Nöel ALBERTINI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 24, 2018</study_first_submitted>
  <study_first_submitted_qc>September 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2018</study_first_posted>
  <last_update_submitted>January 24, 2020</last_update_submitted>
  <last_update_submitted_qc>January 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>decolonization</keyword>
  <keyword>mupirocin</keyword>
  <keyword>cardiac surgery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

